UniProt ID | TCPZ_HUMAN | |
---|---|---|
UniProt AC | P40227 | |
Protein Name | T-complex protein 1 subunit zeta | |
Gene Name | CCT6A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 531 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Molecular chaperone; assists the folding of proteins upon ATP hydrolysis. Known to play a role, in vitro, in the folding of actin and tubulin.. | |
Protein Sequence | MAAVKTLNPKAEVARAQAALAVNISAARGLQDVLRTNLGPKGTMKMLVSGAGDIKLTKDGNVLLHEMQIQHPTASLIAKVATAQDDITGDGTTSNVLIIGELLKQADLYISEGLHPRIITEGFEAAKEKALQFLEEVKVSREMDRETLIDVARTSLRTKVHAELADVLTEAVVDSILAIKKQDEPIDLFMIEIMEMKHKSETDTSLIRGLVLDHGARHPDMKKRVEDAYILTCNVSLEYEKTEVNSGFFYKSAEEREKLVKAERKFIEDRVKKIIELKRKVCGDSDKGFVVINQKGIDPFSLDALSKEGIVALRRAKRRNMERLTLACGGVALNSFDDLSPDCLGHAGLVYEYTLGEEKFTFIEKCNNPRSVTLLIKGPNKHTLTQIKDAVRDGLRAVKNAIDDGCVVPGAGAVEVAMAEALIKHKPSVKGRAQLGVQAFADALLIIPKVLAQNSGFDLQETLVKIQAEHSESGQLVGVDLNTGEPMVAAEVGVWDNYCVKKQLLHSCTVIATNILLVDEIMRAGMSSLKG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAVKTLNP ------CCCCCCCCH | 22.44 | 22814378 | |
5 | Ubiquitination | ---MAAVKTLNPKAE ---CCCCCCCCHHHH | 42.44 | 21890473 | |
5 | 2-Hydroxyisobutyrylation | ---MAAVKTLNPKAE ---CCCCCCCCHHHH | 42.44 | - | |
5 | Acetylation | ---MAAVKTLNPKAE ---CCCCCCCCHHHH | 42.44 | 19608861 | |
5 | Methylation | ---MAAVKTLNPKAE ---CCCCCCCCHHHH | 42.44 | 19608861 | |
5 | Ubiquitination | ---MAAVKTLNPKAE ---CCCCCCCCHHHH | 42.44 | 21890473 | |
6 | Phosphorylation | --MAAVKTLNPKAEV --CCCCCCCCHHHHH | 25.76 | 24719451 | |
10 | Ubiquitination | AVKTLNPKAEVARAQ CCCCCCHHHHHHHHH | 56.98 | 21890473 | |
10 | Sumoylation | AVKTLNPKAEVARAQ CCCCCCHHHHHHHHH | 56.98 | - | |
10 | Acetylation | AVKTLNPKAEVARAQ CCCCCCHHHHHHHHH | 56.98 | 23954790 | |
10 | Malonylation | AVKTLNPKAEVARAQ CCCCCCHHHHHHHHH | 56.98 | 26320211 | |
10 | Sumoylation | AVKTLNPKAEVARAQ CCCCCCHHHHHHHHH | 56.98 | 19608861 | |
10 | Ubiquitination | AVKTLNPKAEVARAQ CCCCCCHHHHHHHHH | 56.98 | 21890473 | |
35 | Methylation | RGLQDVLRTNLGPKG HCHHHHHHCCCCCCC | 22.78 | - | |
41 | Acetylation | LRTNLGPKGTMKMLV HHCCCCCCCCEEEEE | 66.28 | 26051181 | |
41 | Ubiquitination | LRTNLGPKGTMKMLV HHCCCCCCCCEEEEE | 66.28 | - | |
45 | 2-Hydroxyisobutyrylation | LGPKGTMKMLVSGAG CCCCCCEEEEECCCC | 28.99 | - | |
45 | Ubiquitination | LGPKGTMKMLVSGAG CCCCCCEEEEECCCC | 28.99 | - | |
46 | Sulfoxidation | GPKGTMKMLVSGAGD CCCCCEEEEECCCCC | 2.87 | 21406390 | |
55 | Acetylation | VSGAGDIKLTKDGNV ECCCCCEEECCCCCE | 55.64 | 25953088 | |
55 | Ubiquitination | VSGAGDIKLTKDGNV ECCCCCEEECCCCCE | 55.64 | 21906983 | |
57 | Phosphorylation | GAGDIKLTKDGNVLL CCCCEEECCCCCEEE | 23.30 | 20068231 | |
58 | Ubiquitination | AGDIKLTKDGNVLLH CCCEEECCCCCEEEE | 74.25 | 21890473 | |
58 | 2-Hydroxyisobutyrylation | AGDIKLTKDGNVLLH CCCEEECCCCCEEEE | 74.25 | - | |
58 | Ubiquitination | AGDIKLTKDGNVLLH CCCEEECCCCCEEEE | 74.25 | 21890473 | |
58 (in isoform 2) | Ubiquitination | - | 74.25 | - | |
67 | Sulfoxidation | GNVLLHEMQIQHPTA CCEEEEEEEECCCCH | 2.71 | 30846556 | |
73 | Phosphorylation | EMQIQHPTASLIAKV EEEECCCCHHHHHHH | 27.10 | 20068231 | |
75 | Phosphorylation | QIQHPTASLIAKVAT EECCCCHHHHHHHHC | 23.84 | 20068231 | |
79 | Ubiquitination | PTASLIAKVATAQDD CCHHHHHHHHCCCCC | 25.96 | - | |
82 | Phosphorylation | SLIAKVATAQDDITG HHHHHHHCCCCCCCC | 28.04 | 21712546 | |
93 | Phosphorylation | DITGDGTTSNVLIIG CCCCCCCCCCEEECH | 24.67 | 21712546 | |
94 | Phosphorylation | ITGDGTTSNVLIIGE CCCCCCCCCEEECHH | 25.44 | 21712546 | |
104 | Ubiquitination | LIIGELLKQADLYIS EECHHHHHHCCEEEC | 56.94 | - | |
109 | Phosphorylation | LLKQADLYISEGLHP HHHHCCEEECCCCCH | 11.71 | 21406692 | |
111 | Phosphorylation | KQADLYISEGLHPRI HHCCEEECCCCCHHH | 16.44 | 21406692 | |
120 | Phosphorylation | GLHPRIITEGFEAAK CCCHHHHHCCHHHHH | 27.90 | - | |
127 | Acetylation | TEGFEAAKEKALQFL HCCHHHHHHHHHHHH | 67.79 | 25038526 | |
127 | Ubiquitination | TEGFEAAKEKALQFL HCCHHHHHHHHHHHH | 67.79 | 21906983 | |
129 | 2-Hydroxyisobutyrylation | GFEAAKEKALQFLEE CHHHHHHHHHHHHHH | 54.40 | - | |
129 | Acetylation | GFEAAKEKALQFLEE CHHHHHHHHHHHHHH | 54.40 | 25953088 | |
129 | Ubiquitination | GFEAAKEKALQFLEE CHHHHHHHHHHHHHH | 54.40 | 21906983 | |
138 | 2-Hydroxyisobutyrylation | LQFLEEVKVSREMDR HHHHHHHHCCHHCCH | 37.46 | - | |
138 | Ubiquitination | LQFLEEVKVSREMDR HHHHHHHHCCHHCCH | 37.46 | 21906983 | |
143 | Sulfoxidation | EVKVSREMDRETLID HHHCCHHCCHHHHHH | 5.98 | 21406390 | |
154 | Acetylation | TLIDVARTSLRTKVH HHHHHHHHHHHHHHH | 23.52 | 19608861 | |
154 | Ubiquitination | TLIDVARTSLRTKVH HHHHHHHHHHHHHHH | 23.52 | 19608861 | |
159 | Ubiquitination | ARTSLRTKVHAELAD HHHHHHHHHHHHHHH | 26.11 | - | |
180 | 2-Hydroxyisobutyrylation | VDSILAIKKQDEPID HHHHHHHHCCCCCCC | 38.48 | - | |
180 | Ubiquitination | VDSILAIKKQDEPID HHHHHHHHCCCCCCC | 38.48 | - | |
190 | Sulfoxidation | DEPIDLFMIEIMEMK CCCCCEEEEEHHHHH | 3.32 | 30846556 | |
194 | Sulfoxidation | DLFMIEIMEMKHKSE CEEEEEHHHHHCCCC | 2.39 | 30846556 | |
196 | Sulfoxidation | FMIEIMEMKHKSETD EEEEHHHHHCCCCCC | 2.81 | 30846556 | |
197 | Acetylation | MIEIMEMKHKSETDT EEEHHHHHCCCCCCC | 34.28 | 25038526 | |
199 | 2-Hydroxyisobutyrylation | EIMEMKHKSETDTSL EHHHHHCCCCCCCHH | 44.46 | - | |
199 | Acetylation | EIMEMKHKSETDTSL EHHHHHCCCCCCCHH | 44.46 | 19608861 | |
199 | Malonylation | EIMEMKHKSETDTSL EHHHHHCCCCCCCHH | 44.46 | 26320211 | |
199 | Ubiquitination | EIMEMKHKSETDTSL EHHHHHCCCCCCCHH | 44.46 | 19608861 | |
200 | Phosphorylation | IMEMKHKSETDTSLI HHHHHCCCCCCCHHH | 45.51 | 23403867 | |
202 | Phosphorylation | EMKHKSETDTSLIRG HHHCCCCCCCHHHHH | 52.23 | 23403867 | |
204 | Phosphorylation | KHKSETDTSLIRGLV HCCCCCCCHHHHHHH | 32.62 | 29255136 | |
205 | Phosphorylation | HKSETDTSLIRGLVL CCCCCCCHHHHHHHH | 25.30 | 19664994 | |
206 | Ubiquitination | KSETDTSLIRGLVLD CCCCCCHHHHHHHHC | 3.16 | 21890473 | |
223 | Ubiquitination | ARHPDMKKRVEDAYI CCCCCHHHHHHHEEE | 55.85 | - | |
229 | Phosphorylation | KKRVEDAYILTCNVS HHHHHHEEEEEEEEE | 14.58 | 28152594 | |
232 | Phosphorylation | VEDAYILTCNVSLEY HHHEEEEEEEEEEEE | 7.77 | 28152594 | |
239 | Phosphorylation | TCNVSLEYEKTEVNS EEEEEEEEEEEEECC | 28.19 | 22817900 | |
241 | Ubiquitination | NVSLEYEKTEVNSGF EEEEEEEEEEECCCC | 49.43 | - | |
242 | Ubiquitination | VSLEYEKTEVNSGFF EEEEEEEEEECCCCC | 32.97 | 21890473 | |
246 | Phosphorylation | YEKTEVNSGFFYKSA EEEEEECCCCCCCCH | 42.00 | 21945579 | |
250 | Ubiquitination | EVNSGFFYKSAEERE EECCCCCCCCHHHHH | 11.19 | 21890473 | |
250 | Phosphorylation | EVNSGFFYKSAEERE EECCCCCCCCHHHHH | 11.19 | 21945579 | |
251 | 2-Hydroxyisobutyrylation | VNSGFFYKSAEEREK ECCCCCCCCHHHHHH | 37.72 | - | |
251 | Acetylation | VNSGFFYKSAEEREK ECCCCCCCCHHHHHH | 37.72 | 23236377 | |
251 | Succinylation | VNSGFFYKSAEEREK ECCCCCCCCHHHHHH | 37.72 | 23954790 | |
251 | Sumoylation | VNSGFFYKSAEEREK ECCCCCCCCHHHHHH | 37.72 | 28112733 | |
251 | Ubiquitination | VNSGFFYKSAEEREK ECCCCCCCCHHHHHH | 37.72 | 21890473 | |
258 | Ubiquitination | KSAEEREKLVKAERK CCHHHHHHHHHHHHH | 65.87 | - | |
262 | Ubiquitination | EREKLVKAERKFIED HHHHHHHHHHHHHHH | 17.85 | 21890473 | |
265 | Acetylation | KLVKAERKFIEDRVK HHHHHHHHHHHHHHH | 42.05 | 26051181 | |
265 | Ubiquitination | KLVKAERKFIEDRVK HHHHHHHHHHHHHHH | 42.05 | - | |
272 | Ubiquitination | KFIEDRVKKIIELKR HHHHHHHHHHHHHHH | 38.87 | - | |
278 | Ubiquitination | VKKIIELKRKVCGDS HHHHHHHHHHHHCCC | 37.07 | - | |
280 | Acetylation | KIIELKRKVCGDSDK HHHHHHHHHHCCCCC | 40.05 | 7481305 | |
280 | Malonylation | KIIELKRKVCGDSDK HHHHHHHHHHCCCCC | 40.05 | 26320211 | |
280 | Ubiquitination | KIIELKRKVCGDSDK HHHHHHHHHHCCCCC | 40.05 | - | |
282 | Glutathionylation | IELKRKVCGDSDKGF HHHHHHHHCCCCCCE | 5.86 | 22555962 | |
285 | Phosphorylation | KRKVCGDSDKGFVVI HHHHHCCCCCCEEEE | 26.89 | 23401153 | |
287 | 2-Hydroxyisobutyrylation | KVCGDSDKGFVVINQ HHHCCCCCCEEEEEC | 59.19 | - | |
287 | Acetylation | KVCGDSDKGFVVINQ HHHCCCCCCEEEEEC | 59.19 | 23749302 | |
287 | Ubiquitination | KVCGDSDKGFVVINQ HHHCCCCCCEEEEEC | 59.19 | 21906983 | |
295 | Acetylation | GFVVINQKGIDPFSL CEEEEECCCCCCCCH | 54.03 | 23954790 | |
295 | Ubiquitination | GFVVINQKGIDPFSL CEEEEECCCCCCCCH | 54.03 | 21890473 | |
301 | Phosphorylation | QKGIDPFSLDALSKE CCCCCCCCHHHHCHH | 30.63 | 23401153 | |
306 | Phosphorylation | PFSLDALSKEGIVAL CCCHHHHCHHHHHHH | 30.31 | 21712546 | |
307 | 2-Hydroxyisobutyrylation | FSLDALSKEGIVALR CCHHHHCHHHHHHHH | 61.89 | - | |
307 | Ubiquitination | FSLDALSKEGIVALR CCHHHHCHHHHHHHH | 61.89 | 21906983 | |
314 | Methylation | KEGIVALRRAKRRNM HHHHHHHHHHHHHCC | 27.12 | - | |
320 | Acetylation | LRRAKRRNMERLTLA HHHHHHHCCHHHHHH | 40.47 | 19608861 | |
320 | Ubiquitination | LRRAKRRNMERLTLA HHHHHHHCCHHHHHH | 40.47 | 19608861 | |
332 | Ubiquitination | TLACGGVALNSFDDL HHHHCCCHHCCCCCC | 12.33 | 21890473 | |
332 | Acetylation | TLACGGVALNSFDDL HHHHCCCHHCCCCCC | 12.33 | 19608861 | |
332 | Ubiquitination | TLACGGVALNSFDDL HHHHCCCHHCCCCCC | 12.33 | 19608861 | |
336 | Ubiquitination | GGVALNSFDDLSPDC CCCHHCCCCCCCCCC | 9.13 | 21890473 | |
343 | Acetylation | FDDLSPDCLGHAGLV CCCCCCCCCCCCEEE | 5.79 | 19608861 | |
365 | 2-Hydroxyisobutyrylation | EKFTFIEKCNNPRSV CEEEEEECCCCCCEE | 37.13 | - | |
365 | Acetylation | EKFTFIEKCNNPRSV CEEEEEECCCCCCEE | 37.13 | 19608861 | |
365 | Malonylation | EKFTFIEKCNNPRSV CEEEEEECCCCCCEE | 37.13 | 26320211 | |
365 | Succinylation | EKFTFIEKCNNPRSV CEEEEEECCCCCCEE | 37.13 | 27452117 | |
365 | Ubiquitination | EKFTFIEKCNNPRSV CEEEEEECCCCCCEE | 37.13 | 19608861 | |
377 | Acetylation | RSVTLLIKGPNKHTL CEEEEEEECCCCCCH | 69.18 | 19608861 | |
377 | Malonylation | RSVTLLIKGPNKHTL CEEEEEEECCCCCCH | 69.18 | 26320211 | |
377 | Ubiquitination | RSVTLLIKGPNKHTL CEEEEEEECCCCCCH | 69.18 | 21890473 | |
381 | 2-Hydroxyisobutyrylation | LLIKGPNKHTLTQIK EEEECCCCCCHHHHH | 40.89 | - | |
381 | Acetylation | LLIKGPNKHTLTQIK EEEECCCCCCHHHHH | 40.89 | 25953088 | |
381 | Malonylation | LLIKGPNKHTLTQIK EEEECCCCCCHHHHH | 40.89 | 26320211 | |
381 | Ubiquitination | LLIKGPNKHTLTQIK EEEECCCCCCHHHHH | 40.89 | 21890473 | |
383 | Phosphorylation | IKGPNKHTLTQIKDA EECCCCCCHHHHHHH | 32.86 | 23312004 | |
388 | 2-Hydroxyisobutyrylation | KHTLTQIKDAVRDGL CCCHHHHHHHHHHHH | 29.80 | - | |
388 | Acetylation | KHTLTQIKDAVRDGL CCCHHHHHHHHHHHH | 29.80 | 19608861 | |
388 | Malonylation | KHTLTQIKDAVRDGL CCCHHHHHHHHHHHH | 29.80 | 26320211 | |
388 | Succinylation | KHTLTQIKDAVRDGL CCCHHHHHHHHHHHH | 29.80 | 23954790 | |
388 | Ubiquitination | KHTLTQIKDAVRDGL CCCHHHHHHHHHHHH | 29.80 | 19608861 | |
396 | Methylation | DAVRDGLRAVKNAID HHHHHHHHHHHHHCC | 42.75 | - | |
399 | 2-Hydroxyisobutyrylation | RDGLRAVKNAIDDGC HHHHHHHHHHCCCCC | 39.41 | - | |
399 | Ubiquitination | RDGLRAVKNAIDDGC HHHHHHHHHHCCCCC | 39.41 | - | |
406 | S-nitrosocysteine | KNAIDDGCVVPGAGA HHHCCCCCCCCCCCH | 3.43 | - | |
406 | Glutathionylation | KNAIDDGCVVPGAGA HHHCCCCCCCCCCCH | 3.43 | 22555962 | |
406 | S-nitrosylation | KNAIDDGCVVPGAGA HHHCCCCCCCCCCCH | 3.43 | 22178444 | |
418 | Sulfoxidation | AGAVEVAMAEALIKH CCHHHHHHHHHHHHC | 4.12 | 30846556 | |
424 | Ubiquitination | AMAEALIKHKPSVKG HHHHHHHHCCCCCCC | 46.56 | - | |
426 | Ubiquitination | AEALIKHKPSVKGRA HHHHHHCCCCCCCCH | 33.70 | - | |
455 | Phosphorylation | PKVLAQNSGFDLQET HHHHHHCCCCCHHHH | 28.85 | 25693802 | |
485 | Ubiquitination | GVDLNTGEPMVAAEV EEECCCCCCEEEEEC | 28.34 | 21890473 | |
527 | Phosphorylation | EIMRAGMSSLKG--- HHHHHHHHHCCC--- | 31.44 | 28348404 | |
528 | Phosphorylation | IMRAGMSSLKG---- HHHHHHHHCCC---- | 25.80 | 28348404 | |
530 | Acetylation | RAGMSSLKG------ HHHHHHCCC------ | 65.60 | 27452117 | |
530 | Ubiquitination | RAGMSSLKG------ HHHHHHCCC------ | 65.60 | 21906983 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TCPZ_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TCPZ_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TCPZ_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
UBP5_HUMAN | USP5 | physical | 22939629 | |
VIME_HUMAN | VIM | physical | 22939629 | |
TCPG_HUMAN | CCT3 | physical | 22863883 | |
TCPD_HUMAN | CCT4 | physical | 22863883 | |
TCPQ_HUMAN | CCT8 | physical | 22863883 | |
EF1D_HUMAN | EEF1D | physical | 22863883 | |
AT1A1_HUMAN | ATP1A1 | physical | 26344197 | |
ATPG_HUMAN | ATP5C1 | physical | 26344197 | |
TCPB_HUMAN | CCT2 | physical | 26344197 | |
TCPG_HUMAN | CCT3 | physical | 26344197 | |
TCPD_HUMAN | CCT4 | physical | 26344197 | |
TCPH_HUMAN | CCT7 | physical | 26344197 | |
TCPQ_HUMAN | CCT8 | physical | 26344197 | |
DNJA1_HUMAN | DNAJA1 | physical | 26344197 | |
DNJA4_HUMAN | DNAJA4 | physical | 26344197 | |
FAS_HUMAN | FASN | physical | 26344197 | |
GFPT1_HUMAN | GFPT1 | physical | 26344197 | |
IDH3A_HUMAN | IDH3A | physical | 26344197 | |
IMA3_HUMAN | KPNA4 | physical | 26344197 | |
PKN2_HUMAN | PKN2 | physical | 26344197 | |
PRS7_HUMAN | PSMC2 | physical | 26344197 | |
RPN1_HUMAN | RPN1 | physical | 26344197 | |
TCPA_HUMAN | TCP1 | physical | 26344197 | |
QCR2_HUMAN | UQCRC2 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-5; LYS-10; LYS-199; LYS-365;LYS-377 AND LYS-388, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-205, AND MASSSPECTROMETRY. |